This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sucampo Pharmaceuticals Inc (SCMP)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 6.42M 4.84M -17.31M -2.76M
Operating Gains/Losses 0.00 0.00 12.00K 1.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -3.97M 1.18M -5.10M -164.00K
(Increase) Decrease in Inventories -163.00K 87.00K -127.00K 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 2.24M -1.45M 2.87M 893.00K
(Decrease) Increase In Other Current Liabilities -4.72M 15.00K 523.00K 3.33M
(Increase) Decrease In Other Working Capital -4.90M -1.07M -725.00K -5.71M
Other Non-Cash Items -815.00K 26.88M -26.15M 1.26M
Net Cash From Continuing Operations -5.42M 12.00M -19.99M -3.35M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -5.42M 12.00M -19.99M -3.35M
Sale of Property, Plant & Equipment 0.00 0.00 25.00K 5.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -168.00K -3.44M -3.28M -333.00K
Acquisitions 0.00 0.00 0.00 -28.12M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -10.83M 26.14M 44.38M -14.90M
Cash Provided by Financing Activities
Net Cash From Investing Activities -13.88M -589.00K 27.90M -11.86M
Issuance of Debt 10.60M 0.00 0.00 12.08M
Cash Used for Financing Activities
Issuance of Capital Stock 7.64M 331.00K 106.00K 14.00K
Repayment of Long-Term Debt -7.54M -7.50M -7.50M 0.00
Repurchase of Capital Stock -336.00K -1.28M -700.00K 0.00
Payment of Cash Dividends 0.00 0.00 0.00 -13.73M
Other Financing Charges, Net 213.00K 0.00 13.00K 0.00
Net Cash From Financing Activities 10.58M -8.45M -8.08M -1.64M
Effect of Exchange Rate Changes 798.00K -1.60M 1.59M 4.66M
Net Change in Cash & Cash Equivalents -7.92M 1.36M 1.42M -12.18M

SCMP Sucampo Pharmaceuticals Inc

Analysts Ratings for SCMP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

SCMP Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs